Arcus Biosciences, Inc. logo RCUS - Arcus Biosciences, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 15
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $31.17 DETAILS
HIGH: $47.00
LOW: $22.00
MEDIAN: $30.00
CONSENSUS: $31.17
UPSIDE: 33.03%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Revenue
Revenue 17 33 26 160 28 26 48 39 145 31 32 29 25 33.7 33 27 18 354.5 9.5 9.5 9.5 9.5 64.5 1.8 1.8 9.8 1.8 1.8 1.8 1.6 4.3 1.2 1.2 1.2 0.2 0 0
Cost of Revenue 2 3 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 15 30 24 160 28 26 48 39 145 31 32 29 25 33.7 33 27 18 354.5 9.5 9.5 9.5 9.5 64.5 1.8 1.8 9.8 1.8 1.8 1.8 1.6 4.3 1.2 1.2 1.2 0.2 0 0
Operating Expenses
R&D Expenses 122 121 141 139 122 101 123 115 109 93 82 84 81 80.2 77 70 61 49.9 71.3 68.8 66.4 48.7 51.8 35.7 23.1 20.7 17.2 25.0 15.6 11.4 12.9 13.7 11.7 12.1 21.4 7.8 5.8
SG&A Expenses 29 26 27 29 28 28 30 30 32 29 30 28 30 27.9 26 26 24 23.3 16.3 16.8 15.8 12.8 11.2 11.4 7.0 6.6 7.8 5.9 5.0 3.6 3.6 3.5 2.9 2.4 1.9 1.8 1.5
Other Expenses (2) (3) (2) 0 0 0 0 0 20 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 149 144 166 168 150 129 153 145 161 122 112 112 111 108.1 103 96 85 73.2 87.6 85.6 82.2 61.5 63.0 47.1 30.1 27.3 25.0 30.9 20.5 15.0 16.4 17.1 14.6 14.6 23.3 9.7 7.3
Operating Income
Operating Income (134) (114) (142) (8) (122) (103) (105) (106) (16) (91) (80) (83) (86) (74.4) (70) (69) (67) 281.3 (78.1) (76.1) (72.7) (52.0) 1.6 (45.4) (28.4) (17.5) (23.2) (29.2) (18.8) (13.5) (12.1) (15.9) (13.3) (13.3) (23.1) (9.7) (7.3)
Interest Expense 3 14 3 2 1 2 1 0 1 0 1 0 1 0.6 0 1 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 0 31 10 10 11 12 14 13 13 11 12 9 9 7.5 5 3 0 0 0.2 0.2 0.2 0.2 0.3 0.3 0.6 0.9 1.3 1.5 1.5 0.8 1.5 1.3 0.6 0.1 0.0 0.1 0.1
Profitability
EBITDA (132) (81) (130) 4 (108) (89) (89) (91) 0 (77) (67) (72) (75) (65.4) (63) (64) (66) 281.9 (77.0) (75.2) (71.8) (50.2) 2.6 (44.4) (27.4) (16.7) (22.4) (28.3) (17.8) (12.5) (11.2) (15.0) (12.5) (12.6) (22.4) (9.0) (6.8)
EBIT (134) (84) (132) 2 (111) (92) (91) (93) (3) (80) (68) (74) (77) (66.9) (65) (66) (67) 281.9 (78.0) (76.0) (72.6) (52.0) 1.6 (45.4) (28.4) (17.5) (23.2) (29.2) (18.8) (13.5) (12.1) (15.9) (13.3) (13.3) (23.1) (9.7) (7.3)
Income Before Tax (128) (98) (135) (8) (112) (94) (92) (93) (4) (80) (69) (74) (78) (67.5) (65) (67) (67) 281.2 (78.0) (76.0) (72.6) (51.9) 1.8 (45.1) (27.8) (16.6) (22.4) (28.1) (17.7) (12.3) (10.8) (13.5) (13.0) (13.2) (23.1) (9.6) (7.2)
Income Tax Expense 0 0 0 0 0 1 0 0 0 1 2 1 2 (0.0) 0 0 1 1.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (128) (98) (135) (8) (112) (94) (92) (93) (4) (81) (71) (75) (80) (67.5) (65) (67) (68) 279.4 (78.0) (76.0) (72.6) (51.9) 1.8 (45.1) (27.8) (16.6) (22.4) (28.1) (17.7) (12.3) (10.8) (13.5) (13.0) (13.2) (23.1) (9.6) (7.2)
Per Share Data
EPS (Basic) -1.02 -0.92 -1.27 0.04 -1.14 -1.03 -1.01 -1.02 -0.05 -1.08 -0.95 -1.02 -1.10 -0.92 -0.84 -0.90 -0.96 3.97 -1.11 -1.09 -1.08 -0.82 0.03 -0.93 -0.63 -0.38 -0.51 -0.64 -0.41 -0.28 -0.25 -0.32 -1.37 -0.54 -0.94 -0.39 -0.29
EPS (Diluted) -1.02 -0.92 -1.27 0.04 -1.14 -1.03 -1.01 -1.02 -0.05 -1.08 -0.95 -1.02 -1.10 -0.92 -0.84 -0.90 -0.96 3.71 -1.11 -1.09 -1.08 -0.82 0.03 -0.93 -0.63 -0.38 -0.51 -0.64 -0.41 -0.28 -0.25 -0.32 -1.37 -0.54 -0.94 -0.39 -0.29
Shares Outstanding 125.4 107.4 106.5 106.1 98.4 91.7 91.4 91.1 86.2 75 74.6 73.2 73 72.6 72.2 71.8 71.2 70.4 70.1 69.7 67.1 63.5 62.6 48.6 44.3 44.1 43.8 43.8 43.5 43.2 42.8 42.5 9.5 24.6 24.6 24.6 24.6
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q1
Current Assets
Cash & Cash Equivalents 201 222 238 248 192 150 201 156 185 127 184 230 238 206 217.6 272.6 548.8 147.9 179.4 320.5 390.3 173.4 221.8 285.2 67.3 57.9 79.0 76.1 68.5 71.1 74.9 170.0 198.1 98.4 (98.9)
Short-Term Investments 621 759 593 663 805 828 888 813 810 632 615 700 716 803 831.1 900.1 664.8 351.4 345.2 400.5 436.7 555.2 560.6 177.3 90.5 130.3 112.0 148.3 173.4 185.5 182.9 95.7 82.1 77.3 197.8
Net Receivables 0 0 14 20 21 25 21 33 40 42 56 37 36 43 30.7 39.0 32.2 746.8 3.1 3.0 6.3 1.7 3.0 0.5 0.3 0.1 5.3 0.1 0 0.1 5.1 0.2 0.1 0.0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 22 26 12 15 13 13 17 20 29 30 26 18 24 14 0 14.4 17.6 14.7 16.6 21.0 0 4.5 8.9 0 0 0.3 0 0 3.1 0 0 0 0 0 0
Total Current Assets 844 1,007 857 946 1,031 1,016 1,127 1,022 1,064 831 881 985 1,014 1,066 1,101.1 1,227.5 1,264.2 1,261.8 545.3 746.0 841.9 735.8 797.2 471.6 166.2 192.7 200.5 227.7 245.0 258.9 265.3 267.4 282.1 176.9 98.9
Non-Current Assets
Property, Plant & Equipment 38 40 42 44 46 47 48 49 51 51 50 45 37 135 136.0 137.4 136.5 137.4 64.4 59.9 27.1 23.6 8.7 8.3 8.8 9.3 10.0 10.4 11.0 11.1 11.8 12.5 11.8 11.2 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 10 16 8 14 2 40 100 107 160 88 96 134 143.1 101.3 131.8 185.0 221.7 87.1 58.0 6.6 2.9 0 0 0 6.0 0.4 2.0 4.4 9.3 13.5 11.1 0.7 0
Other Non-Current Assets 115 92 65 69 71 73 75 75 78 106 100 102 107 10 13.6 10.5 10.9 7.7 7.9 5.8 8.2 6.2 2.2 1.5 1.2 1.1 0.5 0.5 0.5 0.5 0.4 0.4 0.4 1.7 (98.9)
Total Non-Current Assets 153 132 117 129 125 134 125 164 229 264 310 235 240 279 292.7 249.3 279.2 330.1 294.0 152.8 93.2 36.5 13.9 9.8 9.9 10.4 16.5 11.2 13.5 16.0 21.4 26.4 23.3 13.6 (98.9)
Total Assets 997 1,139 974 1,075 1,156 1,150 1,252 1,186 1,293 1,095 1,191 1,220 1,254 1,345 1,393.8 1,476.8 1,543.4 1,591.9 839.3 898.8 935.1 772.3 811.1 481.4 176.1 203.1 217.0 239.0 258.5 274.9 286.7 293.9 305.4 190.5 0
Current Liabilities
Account Payables 0 0 42 29 22 18 13 15 16 17 17 12 28 20 10.5 22.0 18.1 10.3 13.2 17.0 24.5 15.7 8.1 12.1 2.4 4.7 2.9 2.4 2.8 3.1 2.1 5.4 3.9 3.8 0
Short-Term Debt 0 0 0 0 0 0 0 0 0 0 9 0 0 3 0 0 0 5.1 0 0 0 2.9 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 34 35 52 71 72 85 105 113 124 91 103 103 97 97 103.3 90.1 89.3 102.0 74.3 74.6 74.6 74.6 117.5 7 7 7 7 7 7 6.2 6.2 5 5 5 0
Other Current Liabilities 175 196 16 16 17 14 86 2 1 39 46 48 41 48 45.3 39.0 39.4 30.3 41.8 30.2 25.8 19.9 31.0 17.0 9.0 6.4 7.7 14.8 7.2 1.6 5.5 1.6 1.7 0.8 0
Total Current Liabilities 209 231 235 210 192 226 215 199 204 184 200 180 179 193 177.2 164.0 161.3 166.1 142.9 130.4 132.1 121.7 162.9 40.0 21.0 22.7 21.1 26.5 19.0 16.9 16.6 16.4 14.3 12.7 0
Non-Current Liabilities
Long-Term Debt 100 99 98 97 48 48 47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 164 178 152 159 166 157 425 138 140 142 145 144 145 23 16.2 14.7 13.9 5.3 10.2 0.5 10.2 10.2 5.2 4.1 4.2 4.5 4.9 5.3 5.7 6.1 6.4 6.8 7.2 5.3 0
Total Non-Current Liabilities 264 277 303 316 433 439 472 352 382 449 471 474 475 495 517.9 565.4 585.6 584.4 153.8 163.8 138.3 148.3 103.8 12.7 14.5 16.6 18.7 15.8 18.0 23.0 25.0 22.9 24.5 23.9 0
Total Liabilities 473 508 538 526 625 665 687 551 586 633 671 654 654 688 695.1 729.4 746.8 750.4 296.7 294.2 270.3 270.0 266.7 52.7 35.5 39.3 39.7 42.3 37.0 40.0 41.6 39.3 38.8 36.6 0
Stockholders' Equity
Common Stock 2,138 2,116 1,815 1,793 1,775 1,617 1,602 1,582 1,561 1,311 1,291 1,267 1,226 1,206 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (1,613) (1,485) (1,379) (1,244) (1,244) (1,132) (1,038) (946) (853) (849) (768) (697) (622) (542) (474.9) (410.0) (343.3) (275.4) (554.7) (476.7) (400.8) (328.2) (276.3) (278.2) (233.1) (205.3) (188.7) (166.4) (138.3) (122.8) (110.5) (99.7) (86.2) (73.2) 0
Accumulated Other Comprehensive Income (1) 0 0 0 0 0 1 (1) (1) 0 (3) (4) (4) (7) (9.8) (7.2) (4.7) (1.3) (0.1) (0.0) (0.0) 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.0 (0.1) (0.1) (0.1) (0.1) (0.0) (20.0)
Total Stockholders' Equity 524 631 436 549 531 485 565 635 707 462 520 566 600 657 698.7 747.4 796.6 841.5 542.6 604.6 664.8 502.3 544.4 428.7 140.6 163.8 177.2 196.6 221.6 234.9 245.1 254.6 266.6 153.9 99.5
Total Liabilities & Equity 997 1,139 974 1,075 1,156 1,150 1,252 1,186 1,293 1,095 1,191 1,220 1,254 1,345 1,393.8 1,476.8 1,543.4 1,591.9 839.3 898.8 935.1 772.3 811.1 481.4 176.1 203.1 217.0 239.0 258.5 274.9 286.7 293.9 305.4 190.5 99.5
Debt Metrics
Total Debt 100 99 111 109 60 60 58 11 11 11 9 0 0 120 119.2 121.3 114.8 122.0 48.9 49.7 14.7 18.1 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Debt (101) (123) (127) (139) (132) (90) (143) (145) (174) (116) (175) (230) (238) (86) (98.5) (151.3) (434.0) (25.9) (130.5) (270.7) (375.6) (155.3) (221.8) (285.2) (67.3) (57.9) (79.0) (76.1) (68.5) (71.1) (74.9) (170.0) (198.1) (98.4) 98.9
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Operating Activities
Net Income (128) (106) (135) 0 (112) (94) (92) (93) (4) (81) (71) (75) (80) (67.5) (64.9) (67) (68.0) 279.4 (78.0) (76.0) (72.6) (51.9) 1.8 (45.1) (27.8) (16.6) (22.4) (28.1) (17.7) (12.3) (10.8) (13.5) (13.0) (13.2) (23.1) (9.6) (7.2)
Depreciation & Amortization 2 3 2 2 3 3 2 2 3 5 1 2 4 3.4 3.6 2 3.4 2.5 1.6 0.8 0.8 1.8 1 0.9 1.0 0.9 0.9 0.9 1.0 0.9 1.0 0.9 0.8 0.8 0.7 0.6 0.5
Stock-Based Compensation 19 15 14 15 16 17 19 20 20 0 18 18 0 0 0 15 0 0 0 13.4 12.8 7.9 6.0 4.5 3.5 2.4 2.7 2.1 1.7 1.1 1.0 1.1 0.7 0.2 0.1 0.1 0.1
Change in Working Capital (31) (30) 21 (148) (37) (23) 101 (19) (37) (24) (9) 0 (38) (20.5) (34.8) (18) 697.5 (360.3) 6.7 (13.7) (8.3) (8.0) 207.5 15.8 (7.7) 4.3 (8.4) 5.7 (1.5) 3.6 (2.1) 1.8 (1.9) 27.8 (2.2) 1.9 (3.0)
Other Non-Cash Items 0 (2) 1 (2) (2) (3) (4) (4) 16 12 27 (2) 16 14.8 15.2 3 21.1 16.3 15.9 1.5 1.0 0.3 (0.0) (0.1) (0.2) (0.4) (0.3) (0.4) (0.3) (0.4) (0.8) (0.1) (0.1) (0.0) (0.0) (0.0) (0.0)
Operating Cash Flow (138) (120) (97) (133) (132) (100) 26 (94) (2) (88) (63) (57) (98) (69.7) (81.0) (65) 654.0 (62.1) (53.8) (74.0) (66.3) (49.9) 216.3 (23.9) (31.3) (9.5) (27.4) (19.8) (16.8) (7.1) (11.8) (10.9) (13.2) 15.6 (24.2) (6.8) (9.6)
Investing Activities
Capital Expenditure 0 (1) 0 0 (1) (1) (1) 0 (4) (6) (10) (5) (3) (0.4) (1.3) (7) (2.8) (8.5) (7.9) (6.1) (3.6) (1.5) (1.1) (0.3) (0.2) (0.2) (0.6) (0.6) (0.6) (0.3) (1.1) (1.3) (1.1) (0.3) (0.8) (2.2) (2.1)
Acquisitions 0 0 0 0 0 0 0 0 0 0 (21) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (150) (397) (165) (161) (353) (172) (278) (206) (387) (115) (280) (239) (154) (155.6) (322.3) (386) (377.6) (134.0) (214.2) (178.3) (192.4) (170.8) (429.2) (130.8) (8.9) (67.5) (56.4) (51.4) (72.4) (39.5) (131.4) (49.6) (41.1) (59.1) (6.3) (10.1) (21.4)
Sales/Maturities of Investments 264 216 244 298 386 224 250 269 222 149 301 270 286 203.0 344.3 178 112.3 161.4 133.4 187.4 258.9 172.0 43.2 44.0 49.1 55.6 87.3 78.7 87.3 42.3 49.2 34.8 25.6 17.3 19.8 9.1 7
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 21 0 0 (0.2) 2.8 (6) 0 0 0 0 0 0 0 0 0 0 30.9 27.2 14.9 2.8 (82.2) (14.8) (15.4) (41.8) 13.6 (1.0) (14.4)
Investing Cash Flow 114 (182) 79 137 32 51 (29) 63 (169) 28 11 26 129 46.8 23.4 (215) (268.1) 18.9 (88.6) 3.0 62.8 (0.2) (387.1) (87.1) 40.1 (12.1) 30.4 26.7 14.3 2.5 (83.3) (16.1) (16.5) (42.1) 12.7 (3.2) (16.5)
Financing Activities
Net Debt Issuance 0 0 0 49 0 0 47 0 0 0 0 0 0 5 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.0) 0 (0.0) (0.0) 0 (0.0) 0 (0.0) (0.0) (0.0) 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 (2) 1 (1) 1 0 1 3 0 0 0 14 0 5 0 2.2 1.9 1.7 0.3 2.4 0.6 (0.8) 0.0 0.7 0 0.8 (0.0) 0.0 3.2 106.5 0 0 0.0
Financing Cash Flow 3 286 8 52 142 (2) 48 2 229 3 6 23 1 11.2 2.5 4 14.9 11.7 1.3 2.2 222.1 1.7 107.5 328.9 0.6 0.5 (0.0) 0.6 (0.0) 0.8 (0.0) (1.1) 129.4 106.6 0.2 0.6 0.0
Cash Position
Net Change in Cash (21) (16) (10) 56 42 (51) 45 (29) 58 (57) (46) (8) 32 (11.6) (55.0) (276) 400.9 (31.5) (141.1) (68.8) 218.6 (48.4) (63.3) 217.9 9.4 (21.1) 2.9 7.6 (2.6) (3.8) (95.1) (28.1) 99.7 80.1 (11.3) (9.5) (26.1)
Cash at Beginning 225 241 251 192 153 204 159 185 130 184 233 241 206 217.6 272.6 552 147.9 179.4 320.5 392.2 173.6 222.1 285.4 67.5 58.1 79.2 76.3 68.7 71.3 74.9 170.0 198.1 98.4 18.3 29.6 39.1 65.2
Cash at End 204 225 241 248 195 153 204 156 188 127 187 233 238 206 217.6 276 548.8 147.9 179.4 323.5 392.2 173.6 222.1 285.4 67.5 58.1 79.2 76.3 68.7 71.1 74.9 170.0 198.1 98.4 18.3 29.6 39.1
Free Cash Flow (138) (121) (97) (133) (133) (101) 25 (94) (6) (94) (73) (62) (101) (70.1) (82.3) (72) 651.2 (70.6) (61.6) (80.1) (70.0) (51.4) 215.2 (24.2) (31.5) (9.7) (27.9) (20.3) (17.5) (7.4) (12.9) (12.2) (14.3) 15.3 (25.1) (9.1) (11.7)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1
Income Statement
Revenue 17 33 26 160 28 26 48 39 145 31 32 29 25 33.7 33 27 18 354.5 9.5 9.5 9.5 9.5 64.5 1.8 1.8 9.8 1.8 1.8 1.8 1.6 4.3 1.2 1.2 1.2 0.2 0 0
Gross Profit 15 30 24 160 28 26 48 39 145 31 32 29 25 33.7 33 27 18 354.5 9.5 9.5 9.5 9.5 64.5 1.8 1.8 9.8 1.8 1.8 1.8 1.6 4.3 1.2 1.2 1.2 0.2 0 0
Operating Income (134) (114) (142) (8) (122) (103) (105) (106) (16) (91) (80) (83) (86) (74.4) (70) (69) (67) 281.3 (78.1) (76.1) (72.7) (52.0) 1.6 (45.4) (28.4) (17.5) (23.2) (29.2) (18.8) (13.5) (12.1) (15.9) (13.3) (13.3) (23.1) (9.7) (7.3)
Net Income (128) (98) (135) (8) (112) (94) (92) (93) (4) (81) (71) (75) (80) (67.5) (65) (67) (68) 279.4 (78.0) (76.0) (72.6) (51.9) 1.8 (45.1) (27.8) (16.6) (22.4) (28.1) (17.7) (12.3) (10.8) (13.5) (13.0) (13.2) (23.1) (9.6) (7.2)
EPS (Diluted) -1.02 -0.92 -1.27 0.04 -1.14 -1.03 -1.01 -1.02 -0.05 -1.08 -0.95 -1.02 -1.10 -0.92 -0.84 -0.90 -0.96 3.71 -1.11 -1.09 -1.08 -0.82 0.03 -0.93 -0.63 -0.38 -0.51 -0.64 -0.41 -0.28 -0.25 -0.32 -1.37 -0.54 -0.94 -0.39 -0.29
Balance Sheet
Cash & Equivalents 201 222 238 248 192 150 201 156 185 127 184 230 238 206 217.6 272.6 548.8 147.9 179.4 320.5 390.3 173.4 221.8 285.2 67.3 57.9 79.0 76.1 68.5 71.1 74.9 170.0 198.1 98.4 (98.9)
Total Assets 997 1,139 974 1,075 1,156 1,150 1,252 1,186 1,293 1,095 1,191 1,220 1,254 1,345 1,393.8 1,476.8 1,543.4 1,591.9 839.3 898.8 935.1 772.3 811.1 481.4 176.1 203.1 217.0 239.0 258.5 274.9 286.7 293.9 305.4 190.5 0
Total Debt 100 99 111 109 60 60 58 11 11 11 9 0 0 120 119.2 121.3 114.8 122.0 48.9 49.7 14.7 18.1 0 0 0 0 0 0 0 0 0 0 0 0 0
Stockholders' Equity 524 631 436 549 531 485 565 635 707 462 520 566 600 657 698.7 747.4 796.6 841.5 542.6 604.6 664.8 502.3 544.4 428.7 140.6 163.8 177.2 196.6 221.6 234.9 245.1 254.6 266.6 153.9 99.5
Cash Flow
Operating Cash Flow (138) (120) (97) (133) (132) (100) 26 (94) (2) (88) (63) (57) (98) (69.7) (81.0) (65) 654.0 (62.1) (53.8) (74.0) (66.3) (49.9) 216.3 (23.9) (31.3) (9.5) (27.4) (19.8) (16.8) (7.1) (11.8) (10.9) (13.2) 15.6 (24.2) (6.8) (9.6)
Capital Expenditure 0 (1) 0 0 (1) (1) (1) 0 (4) (6) (10) (5) (3) (0.4) (1.3) (7) (2.8) (8.5) (7.9) (6.1) (3.6) (1.5) (1.1) (0.3) (0.2) (0.2) (0.6) (0.6) (0.6) (0.3) (1.1) (1.3) (1.1) (0.3) (0.8) (2.2) (2.1)
Free Cash Flow (138) (121) (97) (133) (133) (101) 25 (94) (6) (94) (73) (62) (101) (70.1) (82.3) (72) 651.2 (70.6) (61.6) (80.1) (70.0) (51.4) 215.2 (24.2) (31.5) (9.7) (27.9) (20.3) (17.5) (7.4) (12.9) (12.2) (14.3) 15.3 (25.1) (9.1) (11.7)